XML 46 R35.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation and Equity (Tables)
9 Months Ended
Sep. 30, 2020
Equity [Abstract]  
Schedule of restricted and conditional award activity
Nonvested restricted share awards (“RSAs”), restricted share units (“RSUs”), and performance share units (“PSUs”) at September 30, 2020 and changes during the nine months ended September 30, 2020 were as follows:
RSA and RSU AwardsPSU Awards
SharesWeighted-Average
Grant Date
Fair Value
SharesWeighted-Average
Grant Date
Fair Value
Nonvested at January 1, 2020283,977 $68.51 331,242 $80.90 
Granted (a)
141,384 81.48 90,518 104.65 
Vested (b)
(159,456)69.57 (156,838)80.42 
Forfeited(5,555)71.69 (6,715)88.94 
Adjustment (c)
— — (18,426)80.27 
Nonvested at September 30, 2020 (d)
260,350 $74.83 239,781 $90.83 
__________
(a)The grant date fair value of RSAs and RSUs reflect our stock price on the date of grant on a one-for-one basis. The grant date fair value of PSUs was determined utilizing (i) a Monte Carlo simulation model to generate an estimate of our future stock price over the three-year performance period and (ii) future financial performance projections. To estimate the fair value of PSUs granted during the nine months ended September 30, 2020, we used a risk-free interest rate of 1.6%, an expected volatility rate of 15.2%, and assumed a dividend yield of zero.
(b)The grant date fair value of shares vested during the nine months ended September 30, 2020 was $23.7 million. Employees have the option to take immediate delivery of the shares upon vesting or defer receipt to a future date pursuant to previously made deferral elections. At September 30, 2020 and December 31, 2019, we had an obligation to issue 986,859 and 893,713 shares, respectively, of our common stock underlying such deferred awards, which is recorded within Total stockholders’ equity as a Deferred compensation obligation of $42.0 million and $37.3 million, respectively.
(c)Vesting and payment of the PSUs is conditioned upon certain company and/or market performance goals being met during the relevant three-year performance period. The ultimate number of PSUs to be vested will depend on the extent to which the performance goals are met and can range from zero to three times the original awards. As a result, we recorded adjustments at September 30, 2020 to reflect the number of shares expected to be issued when the PSUs vest.
(d)At September 30, 2020, total unrecognized compensation expense related to these awards was approximately $23.2 million, with an aggregate weighted-average remaining term of 1.8 years.
Schedule of earnings per share reconciliation The following table summarizes basic and diluted earnings (in thousands, except share amounts):
 Three Months Ended September 30,Nine Months Ended September 30,
 2020201920202019
Net income attributable to W. P. Carey$149,397 $41,339 $320,787 $175,871 
Net income attributable to nonvested participating RSUs
— (10)— (44)
Net income — basic and diluted$149,397 $41,329 $320,787 $175,827 
Weighted-average shares outstanding — basic174,974,185 172,235,066 173,879,068 170,276,085 
Effect of dilutive securities287,627 251,440 264,970 269,580 
Weighted-average shares outstanding — diluted175,261,812 172,486,506 174,144,038 170,545,665 
Reclassification out of accumulated other comprehensive income
The following tables present a reconciliation of changes in Accumulated other comprehensive loss by component for the periods presented (in thousands):
Three Months Ended September 30, 2020
Gains and (Losses) on Derivative InstrumentsForeign Currency Translation AdjustmentsGains and (Losses) on InvestmentsTotal
Beginning balance$16,455 $(307,068)$— $(290,613)
Other comprehensive income before reclassifications(15,558)34,170 — 18,612 
Amounts reclassified from accumulated other comprehensive loss to:
Other gains and (losses)
(1,664)— — (1,664)
Interest expense
548 — — 548 
Total(1,116)— — (1,116)
Net current period other comprehensive income(16,674)34,170 — 17,496 
Net current period other comprehensive income attributable to noncontrolling interests(7)— — (7)
Ending balance$(226)$(272,898)$— $(273,124)
Three Months Ended September 30, 2019
Gains and (Losses) on Derivative InstrumentsForeign Currency Translation AdjustmentsGains and (Losses) on InvestmentsTotal
Beginning balance$12,645 $(273,451)$(11)$(260,817)
Other comprehensive loss before reclassifications16,323 (37,412)11 (21,078)
Amounts reclassified from accumulated other comprehensive loss to:
Other gains and (losses)
(3,512)— — (3,512)
Interest expense
432 — — 432 
Total(3,080)— — (3,080)
Net current period other comprehensive loss13,243 (37,412)11 (24,158)
Ending balance$25,888 $(310,863)$— $(284,975)
Nine Months Ended September 30, 2020
Gains and (Losses) on Derivative InstrumentsForeign Currency Translation AdjustmentsGains and (Losses) on InvestmentsTotal
Beginning balance$13,048 $(268,715)$— $(255,667)
Other comprehensive loss before reclassifications(4,240)(4,183)— (8,423)
Amounts reclassified from accumulated other comprehensive loss to:
Other gains and (losses)
(10,281)— — (10,281)
Interest expense
1,254 — — 1,254 
Total(9,027)— — (9,027)
Net current period other comprehensive loss(13,267)(4,183)— (17,450)
Net current period other comprehensive income attributable to noncontrolling interests(7)— — (7)
Ending balance$(226)$(272,898)$— $(273,124)
Nine Months Ended September 30, 2019
Gains and (Losses) on Derivative InstrumentsForeign Currency Translation AdjustmentsGains and (Losses) on InvestmentsTotal
Beginning balance$14,102 $(269,091)$(7)$(254,996)
Other comprehensive loss before reclassifications20,179 (41,772)(21,586)
Amounts reclassified from accumulated other comprehensive loss to:
Other gains and (losses)
(10,439)— — (10,439)
Interest expense
2,046 — — 2,046 
Total(8,393)— — (8,393)
Net current period other comprehensive loss11,786 (41,772)(29,979)
Ending balance$25,888 $(310,863)$— $(284,975)